anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
RenovoRx | IPO Presentation Deck | 29 slides · page 22 of 29

The slide outlines a clinical trial design comparing standard IV Gemcitabine + Abraxane against RenovoGem intra-arterial treatment.

Pitch deck · appendix_methodology · plan_implementation · dense density

Deck inventory Unlock
More
Slide JSON Deck JSON
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 paragraph 1/1 source-note 1/1 title 2/2
Components 5
process paragraph source-note headline subtitle
Tools 1
Process flow slide · 70%

Induction phase leading to 1:1 randomization into control and test arms, followed by continuation therapy and survival outcome measurement
Metrics 0
∅
No metrics

No metric insight is anchored to this slide.

Frameworks 1
process 80%

The slide uses a flow diagram to represent the clinical trial stages.